MAPT and supranuclear palsy, progressive, 1: In addition, future implementation of deep learning-assisted analyses of tracer uptake is likely to promote standardization of the assessment of tau deposition in different clinical phenotypes, which will allow specific pathophysiological questions related to PSP heterogeneity to be addressed on a larger scale.